Use of Dipeptidyl-Peptidase IV Inhibitors and Bullous Pemphigoid

被引：28
作者：
Schaffer, Clara [1 ]
Buclin, Thierry [2 ]
Jornayvaz, Francois R. [3 ]
Cazzaniga, Simone [4 ,5 ]
Borradori, Luca [4 ]
Gilliet, Michel [1 ]
Feldmeyer, Laurence [1 ,4 ]
机构：
[1] Lausanne Univ, Hosp Ctr, Dept Dermatol & Venereol, Lausanne, Switzerland
[2] Lausanne Univ, Hosp Ctr, Serv Clin Pharmacol, Lausanne, Switzerland
[3] Lausanne Univ, Hosp Ctr, Serv Endocrinol Diabet & Metab, Lausanne, Switzerland
[4] Bern Univ Hosp, Inselspital, Dept Dermatol, CH-3010 Bern, Switzerland
[5] Ctr Studi GISED, Bergamo, Italy
来源：
DERMATOLOGY | 2017年 / 233卷 / 05期
关键词：
DIAGNOSIS;
D O I：
10.1159/000480498
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：401 / 403
页数：3
相关论文
共 16 条
  • [1] [Anonymous], The use of the WHO-UMC system for standardised case causality assessment
  • [2] A Case Report of Bullous Pemphigoid Induced by Dipeptidyl Peptidase-4 Inhibitors
    Aouidad, Iman
    Fite, Charlotte
    Marinho, Eduardo
    Deschamps, Lydia
    Crickx, Beatrice
    Descamps, Vincent
    [J]. JAMA DERMATOLOGY, 2013, 149 (02) : 243 - 245
  • [3] Bullous pemphigoid associated with dipeptidyl peptidase IV inhibitors. A case report and review of literature
    Attaway, Amy
    Mersfelder, Tracey L.
    Vaishnav, Sakshi
    Baker, Joanne K.
    [J]. JOURNAL OF DERMATOLOGICAL CASE REPORTS, 2014, 8 (01): : 24 - 28
  • [4] Babai S, 2014, FUND CLIN PHARMACOL, V28, P49
  • [5] Diagnosis and classification of autoimmune blistering diseases
    Baum, Sharon
    Sakka, Nicole
    Artsi, Ofir
    Trau, Henri
    Barzilai, Aviv
    [J]. AUTOIMMUNITY REVIEWS, 2014, 13 (4-5) : 482 - 489
  • [6] Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database
    Bene, J.
    Moulis, G.
    Bennani, I.
    Auffret, M.
    Coupe, P.
    Babai, S.
    Hillaire-Buys, D.
    Micallef, J.
    Gautier, S.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (02) : 296 - 301
  • [7] Bullous pemphigoid induced by vildagliptin: a report of three cases
    Bene, Johana
    Jacobsoone, Aurelie
    Coupe, Patrick
    Auffret, Marine
    Babai, Samy
    Hillaire-Buys, Dominique
    Jean-Pastor, Marie-Josephe
    Vonarx, Marlene
    Vermersch, Annie
    Tronquoy, Anne-Fleur
    Gautier, Sophie
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2015, 29 (01) : 112 - 114
  • [8] Bullous pemphigoid: From the clinic to the bench
    Di Zenzo, Giovanni
    della Torre, Rocco
    Zambruno, Giovanna
    Borradori, Luca
    [J]. CLINICS IN DERMATOLOGY, 2012, 30 (01) : 3 - 16
  • [9] Dipeptidyl peptidase-IV inhibitors induced bullous pemphigoid: a case report and analysis of cases reported in the European pharmacovigilance database
    Garcia, M.
    Aranburu, M. A.
    Palacios-Zabalza, I.
    Lertxundi, U.
    Aguirre, C.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (03) : 368 - 370
  • [10] Bullous Pemphigoid Associated With Linagliptin Treatment
    Haber, Roger
    Fayad, Alice Mouna
    Stephan, Farid
    Obeid, Grace
    Tomb, Roland
    [J]. JAMA DERMATOLOGY, 2016, 152 (02) : 224 - 226
12